Our Technologies

We have a wide range of techniques and technologies that can help you further your drug discovery project.


Pre-clinical Imaging

The ability to perform non-invasive imaging to assess and study novel therapeutics requires significant investment in infrastructure and highly experienced staff.  At MDC, we have both. We have unrivalled pre-clinical imaging capabilities to accelerate your drug development:

  • In vivo imaging
  • Mass Spectrometry Imaging and Molecular Pathology for ex vivo analysis of tissues
  • Spatial Transcriptomic capability
  • Data integration from multiple pre-clinical imaging modalities to add value


Mass Spectrometry

We can help you navigate through the complex space of current methods and instrumental platforms and find the right solution to advance your project. We can advise on protocols, design novel workflows and acquire and analyse data using the latest MS technologies and analysis tools available in our laboratories at Alderley Park. We specialise in the following areas:

  • Fast and reliable sample profiling (high-throughput, robust MS assays)
  • Needle in a haystack (targeted, sensitive MS assays)
  • Detailed tissue imaging and surface analysis (multiplexed, spatial MS assays)
  • Trace your target (time-resolved, isotope MS assays)
  • Protein structure and stability (large biomolecule MS assays)


Digital Spatial Profiling


Radiochemistry


Advanced Microscopy


Dr Kevin Randall in the laboratory

Mass Spectrometry Imaging


Molecular Profiling


Soluble Biomarker Analysis


Cellular Science

A Strategy for Success

Working in close collaboration with you, our team will define a bespoke project plan, using industry-leading insight and experience to address your project challenges and increase your chance of success.

We can provide guidance where you may need it, find the right partners to help you, fill gaps in your existing project plan and help manage your project delivery. It is what we do.

Lightening the Load

The advantage of partnering with others for some or all of your R&D is twofold: Firstly, you get to keep your internal team lean, agile, focused and cost-effective. Secondly, you gain access to specialist scientific experts and costly technologies in a flexible manner as you need them.

Whether you need to generate complex assay data, source samples or develop a novel biomarker as a potential companion diagnostic, we can offer seamless support.

Finding the Right Partners

The UK is rich with resources in medicines R&D, but the wealth of talent and technology available can feel overwhelming to those with limited time and resources to explore it. We will help you navigate this complex landscape, understand the skills and expertise that you require, and then connect with the people and organisations that can provide them.

Our network of partners spans both the private and public sectors, taking in CROs, universities, research institutes and the NHS. It is a network comprised of some of the sharpest minds that UK medicines discovery has to offer.